8027_GFP-KrasG12C_2B_puro Citations (1)
Originally described in: Mutant KRAS promotes malignant pleural effusion formation.Agalioti T, Giannou AD, Krontira AC, Kanellakis NI, Kati D, Vreka M, Pepe M, Spella M, Lilis I, Zazara DE, Nikolouli E, Spiropoulou N, Papadakis A, Papadia K, Voulgaridis A, Harokopos V, Stamou P, Meiners S, Eickelberg O, Snyder LA, Antimisiaris SG, Kardamakis D, Psallidas I, Marazioti A, Stathopoulos GT Nat Commun. 2017 May 16;8:15205. doi: 10.1038/ncomms15205. PubMed Journal
Articles Citing 8027_GFP-KrasG12C_2B_puro
| Articles |
|---|
| An In Vivo Inflammatory Loop Potentiates KRAS Blockade. Arendt KAM, Ntaliarda G, Armenis V, Kati D, Henning C, Giotopoulou GA, Pepe MAA, Klotz LV, Lamort AS, Hatz RA, Kobold S, Schamberger AC, Stathopoulos GT. Biomedicines. 2022 Mar 3;10(3). pii: biomedicines10030592. doi: 10.3390/biomedicines10030592. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.